Research & Development



  好好地為大漢效力吧,這片土地上的皇帝換人了,土地上的百姓卻沒有換,秦人,漢人,有什麼分別呢。   就像雲瑯永遠懷念那個帶他們吃喝玩樂的老師,卻把那個逼迫他們學習並且不惜動用武力的老師恨個半死。五月婷婷久久大香蕉   不過,看起來他們四個人對自己目前面臨的局面並不感到擔心,至少還沒有到火燒眉毛的時候。色综合   “這本書對我很重要,以後如果想要救治更多的像你這樣傷勢的同袍,我就要弄明白這本書里的學問。一定要小心,不敢損壞了。”   雲瑯敲著腦門道︰“還不是為了始皇陵,我家里必須有各種各樣的人才,如此才能建立起一個嚴密的防御體系。對了,你不問我還要問你呢,那個高世青原本也是我看好的人,你把他帶走到底是為了什麼?這人我以後還能不能用?”久久综合   賈柳子是一個說話算數的人,巴澤爾被濃煙燻得焦黑之後才被放下來。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo